Nihon Toseki Igakkai Zasshi
Online ISSN : 1883-082X
Print ISSN : 1340-3451
ISSN-L : 1340-3451
A hemodialysis patient with ASO effectively treated by PGE1 via extracorporeal circulation during HD
Kaori KanegaeAkihiko OsajimaYujiro WatanabeHirofumi AnaiKayoko SegawaTakeshi SudaTakayuki OhtaMasako IwamotoHiroshi TanakaNarutoshi KabashimaMasahito TamuraTomoko ShimoikeNobuhiro OhnariYasuhide Nakashima
Author information
Keywords: ASO, PGE1
JOURNAL FREE ACCESS

2001 Volume 34 Issue 6 Pages 1101-1105

Details
Abstract
Prostaglandin E1 (PGE1) is known to improve the impaired microcirculation due to peripheral arterial occlusive disease. We report a hemodialysis (HD) patient with arteriosclerosis obliterans (ASO) treated by intravenous PGE1 administration during HD.
A 71-year old man with a history of chronic renal failure and bilateral femoral-popliteal artery bypass surgery for ASO was admitted to our hospital. He presented resting pain of the right lower limb and intermittent claudicatin.
After admission, his renal function was gradually deteriorated and began receiving HD treatment. IADSA revealed stenosis of the right common iliac artery proximal to the previous bypass graft. We performed intraarterial metallic stenting and slowly administrated PGE1 via extracorporeal circulation during HD. One month later (after 14 therapy sessions), he felt no resting pain in the limbs and the pain-free walking distance was increased.
The present case suggests that i. v. PGE1 administration during HD could be a useful treatment in managing HD patients with ASO.
Content from these authors
© The Japanese Society for Dialysis Therapy
Previous article Next article
feedback
Top